Macrophage inflammatory protein-1α is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts

被引:71
作者
Mehrad, B [1 ]
Moore, TA [1 ]
Standiford, TJ [1 ]
机构
[1] Univ Michigan, Med Ctr, Sch Med, Dept Med,Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.4049/jimmunol.165.2.962
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invasive pulmonary aspergillosis is a devastating complication of immunosuppression that usually occurs in neutropenic patients. In this setting, augmentation of the antifungal activity of available immune cells may improve the outcome of the infection. Macrophage inflammatory protein-1 alpha (MIP-1 alpha) is a CC chemokine with potent chemotactic activity for various subsets of mononuclear leukocytes, We therefore tested the hypothesis that the influx of mononuclear cells into the lung in invasive pulmonary aspergillosis is in part mediated by MIP-1 alpha, and the manipulation of this ligand alters the outcome of the infection, We found that in both immunocompetent and neutropenic mice, MIP-1 alpha was induced in the lungs in response to intratracheal administration of Aspergillus fumigatus conidia, In neutrophil-depleted mice challenged with intratracheal conidia, there was evidence of invasive fungal pneumonia associated with a predominantly mononuclear leukocyte infiltrate. Ab-mediated depletion of Mm-1 alpha resulted in a 6-fold increase in mortality in neutropenic mice, which was associated with a 12-fold increase in lung fungal burden. Studies of single-cell suspensions of whole lungs revealed a 36% decrease in total lung leukocyte infiltration as a result of MIP-1 alpha neutralization. Flow cytometry on whole lung suspensions showed a 41% reduction in lung monocyte/macrophages as a result of MIP-1 alpha neutralization, but no difference in other lung leukocyte subsets. These studies indicate that MIP-1 alpha is a critical mediator of host defense against A, fumigatus in the setting of neutropenia and may be an important target in devising future therapeutic strategies against invasive aspergillosis.
引用
收藏
页码:962 / 968
页数:7
相关论文
共 56 条
[1]  
ADDIS B, 1996, SPENCERS PATHOLOGY L, P261
[2]   PROPHYLACTIC EFFICACY OF AEROSOLIZED LIPOSOMAL (AMBISOME) AND NON-LIPOSOMAL (FUNGIZONE) AMPHOTERICIN-B IN MURINE PULMONARY ASPERGILLOSIS [J].
ALLEN, SD ;
SORENSEN, KN ;
NEJDL, MJ ;
DURRANT, C ;
PROFFIT, RT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (06) :1001-1013
[3]   Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis [J].
Cenci, E ;
Mencacci, A ;
d'Ostiani, CF ;
Del Sero, G ;
Mosci, P ;
Montagnoli, C ;
Bacci, A ;
Romani, L .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1750-1760
[4]   REQUIREMENT OF MIP-1-ALPHA FOR AN INFLAMMATORY RESPONSE TO VIRAL-INFECTION [J].
COOK, DN ;
BECK, MA ;
COFFMAN, TM ;
KIRBY, SL ;
SHERIDAN, JF ;
PRAGNELL, IB ;
SMITHIES, O .
SCIENCE, 1995, 269 (5230) :1583-1585
[5]   EFFICACY OF D0870 COMPARED WITH THOSE OF ITRACONAZOLE AND AMPHOTERICIN-B IN 2 MURINE MODELS OF INVASIVE ASPERGILLOSIS [J].
DENNING, DW ;
HALL, L ;
JACKSON, M ;
HOLLIS, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1809-1814
[6]   Therapeutic outcome in invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :608-615
[7]  
DENNING DW, 1990, REV INFECT DIS, V12, P1147
[8]   Invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :781-803
[9]   ACQUIRED-IMMUNITY IN EXPERIMENTAL MURINE ASPERGILLOSIS IS MEDIATED BY MACROPHAGES [J].
DEREPENTIGNY, L ;
PETITBOIS, S ;
BOUSHIRA, M ;
MICHALISZYN, E ;
SENECHAL, S ;
GENDRON, N ;
MONTPLAISIR, S .
INFECTION AND IMMUNITY, 1993, 61 (09) :3791-3802
[10]   The CC chemokine MIP-1α induces a selective monocyte infiltration following intradermal injection into nonhuman primates [J].
Didier, PJ ;
Paradis, TJ ;
Gladue, RP .
INFLAMMATION, 1999, 23 (01) :75-86